These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14 related articles for article (PubMed ID: 31588917)
1. Monoclonal antibody against α-actinin 4 from human umbilical vein endothelial cells inhibits endothelium-dependent vasorelaxation. Won KJ; Lee KP; Kim DK; Jung SH; Lee CK; Lee DH; Yu SY; Park SH; Lee HM; Kim B J Vasc Res; 2013; 50(3):210-20. PubMed ID: 23711888 [TBL] [Abstract][Full Text] [Related]
3. Naphthazarin and methylnaphthazarin cause vascular dysfunction by impairment of endothelium-derived nitric oxide and increased superoxide anion generation. Kang JJ; Lee PJ; Chen YJ; Lee CC; Li CH; Cheng HW; Cheng YW Toxicol In Vitro; 2006 Feb; 20(1):43-51. PubMed ID: 16019186 [TBL] [Abstract][Full Text] [Related]
5. Microvesicles derived from hypoxia/reoxygenation-treated human umbilical vein endothelial cells impair relaxation of rat thoracic aortic rings. Wang SX; Zhang Q; Shang M; Wei S; Liu M; Wang YL; Zhang MX; Wu YN; Liu ML; Song JQ; Liu YX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Nov; 30(6):560-6. PubMed ID: 26016367 [TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody derived by inoculation of human umbilical vein endothelial cells is a potential inhibitor of acetylcholine receptor-linked vasorelaxation. Jung SH; Ryu Y; Lee D; Park SB; Lee KJ; Lee HM; Kim J; Kim B; Won KJ Gen Physiol Biophys; 2019 Nov; 38(6):505-512. PubMed ID: 31588917 [TBL] [Abstract][Full Text] [Related]